Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics
- 1 July 2023
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (8) , 7055-7067
Abstract
Bacteriophages (phages) are viruses that mainly infect bacteria and are ubiquitously distributed in nature, especially to their host. Phage engineering involves nucleic acids manipulation of phage genome for antimicrobial activity directed against pathogens through the applications of molecular biology techniques such as synthetic biology methods, homologous recombination, CRISPY-BRED and CRISPY-BRIP recombineering, rebooting phage-based engineering, and targeted nucleases including CRISPR/Cas9, zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs). Management of bacteria is widely achieved using antibiotics whose mechanism of action has been shown to target both the genetic dogma and the metabolism of pathogens. However, the overuse of antibiotics has caused the emergence of multidrug-resistant (MDR) bacteria which account for nearly 5 million deaths as of 2019 thereby posing threats to the public health sector, particularly by 2050. Lytic phages have drawn attention as a strong alternative to antibiotics owing to the promising efficacy and safety of phage therapy in various models in vivo and human studies. Therefore, harnessing phage genome engineering methods, particularly CRISPR/Cas9 to overcome the limitations such as phage narrow host range, phage resistance or any potential eukaryotic immune response for phage-based enzymes/proteins therapy may designate phage therapy as a strong alternative to antibiotics for combatting bacterial antimicrobial resistance (AMR). Here, the current trends and progress in phage genome engineering techniques and phage therapy are reviewed.Keywords
This publication has 80 references indexed in Scilit:
- Genetic Engineering of Bacteriophages Against Infectious DiseasesFrontiers in Microbiology, 2019
- Phages for Phage Therapy: Isolation, Characterization, and Host Range BreadthPharmaceuticals, 2019
- Utilizing in vitro DNA assembly to engineer a synthetic T7 Nanoluc reporter phage for Escherichia coli detectionIntegrative Biology, 2019
- Modification of T2 phage infectivity towardEscherichia coliO157:H7 via using CRISPR/Cas9FEMS Microbiology Letters, 2019
- Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9Journal of Virology, 2018
- Targeting mechanisms of tailed bacteriophagesNature Reviews Microbiology, 2018
- Genome Engineering with Targetable NucleasesAnnual Review of Biochemistry, 2014
- Genome engineering using the CRISPR-Cas9 systemNature Protocols, 2013
- De Novo Acquisition of Resistance to Three Antibiotics by Escherichia coliMicrobial Drug Resistance, 2011
- Bacteriophage and their lysins for elimination of infectious bacteriaFEMS Microbiology Reviews, 2009